Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Comprehensive Cancer Center of Wake Forest University Identifier:
First received: May 14, 2004
Last updated: June 4, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)